Robert B Bazemore is of Akari Therapeutics Plc. Currently has a direct ownership of 44,642 shares of AKTX, which is worth approximately $50,445. The most recent transaction as insider was on Mar 06, 2025, when has been sold 44,642 shares (American Depositary Shares representing Ordinary Shares) at a price of $1.12 per share, resulting in proceeds of $49,999. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 44.6K
0% 3M change
n/a 12M change
Total Value Held $50,445

Robert B Bazemore Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 06 2025
BUY
Grant, award, or other acquisition
$49,999 $1.12 p/Share
44,642 Added 50.0%
44,642 American Depositary Sh...

Also insider at

EPZM
Epizyme, Inc. Healthcare
NUVB
Nuvation Bio Inc. Healthcare
ARDX
ARDELYX, INC. Healthcare
RBB

Robert B Bazemore

New York, NY

Track Institutional and Insider Activities on AKTX

Follow Akari Therapeutics Plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AKTX shares.

Notify only if

Insider Trading

Get notified when an Akari Therapeutics PLC insider buys or sells AKTX shares.

Notify only if

News

Receive news related to Akari Therapeutics Plc

Track Activities on AKTX